Fairman Group’s Bio-Techne TECH Stock Holding History

Fairman Group’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-12	Closed	-$864	–	332
2024 Q4	$864	Sell	12 -12	-50%	-$881	﹤0.01%	289
2024 Q3	$1.92K	Hold	24	–	–	﹤0.01%	281
2024 Q2	$1.72K	Hold	24	–	–	﹤0.01%	284
2024 Q1	$1.69K	Hold	24	–	–	﹤0.01%	284
2023 Q4	$1.85K	Buy	+24	New	+$1.58K	﹤0.01%	270

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Select Equity Group New York $20.2B AUM 17.52% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Fairman Group's TECH Position: Q1 2025 in Review

Fairman Group sold out of Bio-Techne (TECH) in Q1 2025, closing a stake of 12 shares — an estimated $864 sold.

Fairman Group first reported a position in TECH in Q4 2023 and held it in 5 quarters. The position peaked at $1.92K in Q3 2024. 578 funds tracked by Wall St. Rank hold TECH as of Q1 2025.

Fairman Group reported no remaining Bio-Techne position as of Q1 2025 after selling out during the quarter.
Fairman Group sold 12 Bio-Techne shares in Q1 2025, an estimated $864.
Fairman Group first reported a position in Bio-Techne in Q4 2023 and held it in 5 quarters.
Fairman Group's Bio-Techne position peaked at $1.92K in Q3 2024.
578 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2025.

Based on Fairman Group's 13F filing for Q1 2025, filed 7 May 2025.